Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 865

Sort by

Sort Order Select

Journal Articles

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

Blood (2020) 136 (12): 1442–1455.

https://doi.org/10.1182/blood.2020005957

Published: 2020

Includes: Supplemental data

Journal Articles

I have a gut feeling…

Nelson J. Chao

Blood (2020) 136 (12): 1380.

https://doi.org/10.1182/blood.2020007186

Published: 2020

Journal Articles

Microbiome-intestine cross talk during acute graft-versus-host disease

Hind Rafei, Robert R. Jenq

Blood (2020) 136 (4): 401–409.

https://doi.org/10.1182/blood.2019000950

Published: 2020

Journal Articles

Mouse models usher in precision medicine

Defu Zeng

Blood (2020) 135 (26): 2331–2333.

https://doi.org/10.1182/blood.2020005679

Published: 2020

Journal Articles

An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury

Blood (2020) 135 (26): 2388–2401.

https://doi.org/10.1182/blood.2019004116

Published: 2020

Includes: Supplemental data

Journal Articles

How I treat steroid-refractory acute graft-versus-host disease

Paul J. Martin

Blood (2020) 135 (19): 1630–1638.

https://doi.org/10.1182/blood.2019000960

Published: 2020

Includes: Supplemental data

Journal Articles

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Rosario Di Maggio, MD, Angela Vitrano, PhD, Carmelo Fidone, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Calogera Gerardi, MD, Saveria Campisi, MD, Lorenzo Tesé, MD, Vincenzo Santoro, MD, Barone Rita, MD, Giangreco Antonino, MD, Paolo Rigano, Lorella Pitrolo, MD, Aurelio Maggio, MD

Blood (2019) 134 (Supplement_1): 4810.

https://doi.org/10.1182/blood-2019-124728

Published: 2019

Journal Articles

Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience

Marta Rojas Vasquez, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Raymond Lai, MD PhD FRCP, Curtis Mabilangan, MSc, Burton Catherine, MD FRCPC, Jutta Preiksaitis, MDFRCPC

Blood (2019) 134 (Supplement_1): 1602.

https://doi.org/10.1182/blood-2019-125344

Published: 2019

Journal Articles

Time to Change Our Practice: Experience in the Treatment of Steroid Refractory Graft Versus Host Disease in a Universitary Hospital in Chile

Nicolas Triantafilo, MD, Mauricio Sarmiento Maldonado, MD, Felipe Palacios, MD, James Campbell, MD, Vicente Sandoval, MD, Andres Rojas, MD, Jara Veronica, Soto Katherine, Silvana Arellano, Carla Lorca, Isabel Pizarro, Elizabeth Rivera, Mauricio Galleguillos, Isabel Rodriguez, Pablo Bertin, MD, Mauricio Ocqueteau, MD, Jaime Pereira, MD

Blood (2019) 134 (Supplement_1): 5683.

https://doi.org/10.1182/blood-2019-131737

Published: 2019

Journal Articles

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Chi L. Nguyen, BA, Antonio L.C. Gomes, PhD, Jonathan U. Peled, MD PhD, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Marissa L. Buchan, MS, Peter A. Adintori, MS, RD, CDN, Kate A Markey, PhDMBBS,FRACP, Annelie Clurman, BA, Molly A. Maloy, MS, Sergio A. Giralt, MD, Miguel-Angel Perales, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 597.

https://doi.org/10.1182/blood-2019-130578

Published: 2019

Journal Articles

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Blood (2019) 134 (Supplement_1): 752.

https://doi.org/10.1182/blood-2019-122191

Published: 2019

Journal Articles

Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in Progress

Annelies J. Van Vuren, MD, Bart J. Biemond, MD PhD, Jean-Louis Kerkhoffs, MD PhD, Saskia E.M. Schols, MD PhD, A. W. Rijneveld, MD PhD, Erfan Nur, MD PhD, Richard van Wijk, PhD, Tim Leiner, MD PhD, Joannes J.M. Marx, Emeritus Professor, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 960.

https://doi.org/10.1182/blood-2019-124059

Published: 2019

Journal Articles

Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients

Erfan Nur, MD PhD, Sacha S Zeerleder, MD PhD, Aafke E. Gaartman, MD, Caroline E Rutten, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD, Liesbeth E.M. Suijk, Mette D Hazenberg, MD PhD, Bart J. Biemond, MD PhD

Blood (2019) 134 (Supplement_1): 997.

https://doi.org/10.1182/blood-2019-129403

Published: 2019

Journal Articles

Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors

Cornelis N. De Jong, MD, Ellen Meijer, MD PhD, Katerina Bakunina, Erfan Nur, MD PhD, Marinus van Marwijk Kooij, MD PhD, Marco R. de Groot, MD PhD, Michel van Gelder, MD PhD, Johan A. Maertens, MD PhD, Jurgen H.E. Kuball, MD PhD, Dries Deeren, MD PhD, Bronno van der Holt, PhD, Jan J Cornelissen, MD PhD, Annoek E.C. Broers, MD PhD

Blood (2019) 134 (Supplement_1): 1.

https://doi.org/10.1182/blood-2019-124659

Published: 2019

Journal Articles

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Shernan Holtan, MD, Todd E. DeFor, MS, Armin Rashidi, MD PhD, Alexander Khoruts, MD, Christopher Staley, PhD, Lucie M Turcotte, MD, Pamala A. Jacobson, PharmD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2019) 134 (Supplement_1): 39.

https://doi.org/10.1182/blood-2019-129236

Published: 2019

Journal Articles

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Gao Mengge, Yan Hong, Yuqian Sun, MD, Jun Kong, MD, Chenhua Yan, PhD, Zhidong Wang, PhD, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2019) 134 (Supplement_1): 2001.

https://doi.org/10.1182/blood-2019-127722

Published: 2019

Journal Articles

Evidence of Endothelial Dysfunction and Activation of RhoA/Rho Kinase Pathway in Inflammatory Bowel Disease

Jaime Pereira, MD, Claudia G Saez, PhD, Manuel Alvarez, MD, Felipe Silva, MD, Nixa Olivares, Jose G Valenzuela, Antonia Pastore, Diego Mezzano, MD

Blood (2019) 134 (Supplement_1): 3641.

https://doi.org/10.1182/blood-2019-126033

Published: 2019

Journal Articles

Bosutinib in the Real-Life Treatment of Chronic Phase Chronic Myeloid Leukemia (CML) Patients Aged > 65 Years Resistant/Intolerant to Frontline Tyrosine-Kynase Inhibitors

Blood (2019) 134 (Supplement_1): 1649.

https://doi.org/10.1182/blood-2019-127029

Published: 2019

Journal Articles

Making Progress in Graft-Versus-Host Disease Prophylaxis and Microbiome Analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/MI-Immune (1801)

Shernan Holtan, MD, Ami S. Bhatt, MD PhD, Raphael Fraser, PhD, Miguel-Angel Perales, MD, Leslie Kean, MD PhD, Wael Saber, MD MS, Mehdi Hamadani, MD, Brent R. Logan, Javier Bolaños-Meade, MD

Blood (2019) 134 (Supplement_1): 2005.

https://doi.org/10.1182/blood-2019-122782

Published: 2019

Journal Articles

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment

Dujardin Adèle, Pierre Morel, MD, Alexis Caulier, MD, Magalie Joris, MD, Amandine Charbonnier, MD, Berengere Gruson, MD, Marine Quint, Marie-Noëlle Lacassagne, Sandrine Castelain, MD PhD, Jean-Pierre Marolleau, MD PhD, Delphine Lebon, MD

Blood (2019) 134 (Supplement_1): 2007.

https://doi.org/10.1182/blood-2019-123283

Published: 2019

NARROW

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

I have a gut feeling…

Microbiome-intestine cross talk during acute graft-versus-host disease

Mouse models usher in precision medicine

An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury

How I treat steroid-refractory acute graft-versus-host disease

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience

Time to Change Our Practice: Experience in the Treatment of Steroid Refractory Graft Versus Host Disease in a Universitary Hospital in Chile

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in Progress

Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients

Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Evidence of Endothelial Dysfunction and Activation of RhoA/Rho Kinase Pathway in Inflammatory Bowel Disease

Bosutinib in the Real-Life Treatment of Chronic Phase Chronic Myeloid Leukemia (CML) Patients Aged > 65 Years Resistant/Intolerant to Frontline Tyrosine-Kynase Inhibitors

Making Progress in Graft-Versus-Host Disease Prophylaxis and Microbiome Analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/MI-Immune (1801)

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only